Lunai Bioworks, Inc. (LNAI)
1.93
-0.01
(-0.52%)
USD |
NASDAQ |
Sep 25, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 19:59
Lunai Bioworks Total Liabilities (Quarterly) : 19.41M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 19.41M |
| December 31, 2025 | 20.22M |
| September 30, 2025 | 20.00M |
| June 30, 2025 | 29.58M |
| March 31, 2025 | 29.34M |
| December 31, 2024 | 29.28M |
| September 30, 2024 | 23.75M |
| June 30, 2024 | 31.15M |
| March 31, 2024 | 43.68M |
| December 31, 2023 | 14.42M |
| September 30, 2023 | 10.82M |
| June 30, 2023 | 11.80M |
| March 31, 2023 | 12.60M |
| December 31, 2022 | 13.37M |
| September 30, 2022 | 12.75M |
| June 30, 2022 | 12.01M |
| March 31, 2022 | 18.86M |
| December 31, 2021 | 17.52M |
| September 30, 2021 | 17.09M |
| June 30, 2021 | 14.94M |
| March 31, 2021 | 11.38M |
| December 31, 2020 | 10.94M |
| September 30, 2020 | 10.90M |
| June 30, 2020 | 11.83M |
| March 31, 2020 | 10.29M |
| Date | Value |
|---|---|
| December 31, 2019 | 7.077M |
| September 30, 2019 | 8.438M |
| June 30, 2019 | 6.777M |
| March 31, 2019 | 25.34M |
| December 31, 2018 | 25.24M |
| September 30, 2018 | 22.21M |
| June 30, 2018 | 23.76M |
| March 31, 2018 | 0.9061M |
| December 31, 2017 | 5.974M |
| September 30, 2017 | 0.9514M |
| June 30, 2017 | 2.989M |
| March 31, 2017 | 1.988M |
| December 31, 2016 | 1.715M |
| September 30, 2016 | 1.743M |
| June 30, 2016 | 1.508M |
| March 31, 2016 | 1.044M |
| December 31, 2015 | 0.8939M |
| September 30, 2015 | 1.014M |
| June 30, 2015 | |
| March 31, 2015 | 0.972M |
| December 31, 2014 | 1.758M |
| September 30, 2014 | 4.933M |
| June 30, 2014 | 3.349M |
| March 31, 2014 | |
| December 31, 2013 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.860M |
| Shareholders Equity (Quarterly) | -9.553M |
| Debt to Equity Ratio | -0.1477 |
| Current Ratio | 0.1936 |
| Net Debt Paydown Yield | 6.80% |